If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Medical Education
Download FREE Excerpt
9 Info Graphics
17 Data Graphics
3 Best Practices
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Professional Medical Education programs are a key way that healthcare professionals learn how to safely and effectively use new medical devices and biopharmaceutical products. While this remains as true today as it was in the past, the changing financial and regulatory landscape has created a challenging environment for Medical Education groups.
With budgets across both pharma and medical device under increasing pressure, it has become critical for Medical Education groups to become more efficient with their resources. This Best Practices, LLC study explores how medical device and biopharmaceutical companies are allocating budget and spend within Medical Education to succeed in this environment. In addition, this evidence-based benchmark study informs Medical Education leaders on where funding originates, how to utilize different funding distribution channels, and funding trends that are emerging within Medical Education.
The study in this report are presented in two segments: Medical Device and Pharmaceutical.
Consumer Products; Diagnostic; Pharmaceutical; Medical Device; Health Care; Technology; Orthopaedics; Biotech; Biopharmaceutical; Clinical Research; Laboratories
Bayer Healthcare; Becton Dickinson; Boston Scientific; Covidien; Bard; Ethicon Endo Surgery; Medrad; Medtronic; Orthofix; Philips; Smith and Nephew; Terumo; Zimmer; Amylin; Astellas Pharma; AstraZeneca; Baxter; Boehringer Ingelheim; Novartis; Sanofi; UCB; Gilead; Esteve; Grunenthal; Insight Pharmaceuticals; Johnson & Johnson; Regeneron; Stallergenes; Xanodyne
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.